NO972006D0 - Ny metode for diagnose av sykdommer - Google Patents

Ny metode for diagnose av sykdommer

Info

Publication number
NO972006D0
NO972006D0 NO972006A NO972006A NO972006D0 NO 972006 D0 NO972006 D0 NO 972006D0 NO 972006 A NO972006 A NO 972006A NO 972006 A NO972006 A NO 972006A NO 972006 D0 NO972006 D0 NO 972006D0
Authority
NO
Norway
Prior art keywords
diagnosis
disease
diseases
new method
condition
Prior art date
Application number
NO972006A
Other languages
English (en)
Inventor
Anders Loenneborg
Praveen Sharma
Original Assignee
Forskningsparken I Aas As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskningsparken I Aas As filed Critical Forskningsparken I Aas As
Priority to NO972006A priority Critical patent/NO972006D0/no
Publication of NO972006D0 publication Critical patent/NO972006D0/no
Priority to DE69828392T priority patent/DE69828392T2/de
Priority to EP03075068A priority patent/EP1323728B1/en
Priority to EP98919350A priority patent/EP0979308B1/en
Priority to DK03075068T priority patent/DK1323728T3/da
Priority to JP54675698A priority patent/JP4163758B2/ja
Priority to DE69840154T priority patent/DE69840154D1/de
Priority to DK98919350T priority patent/DK0979308T3/da
Priority to ES03075068T priority patent/ES2316693T3/es
Priority to ES98919350T priority patent/ES2230688T3/es
Priority to AT03075068T priority patent/ATE412003T1/de
Priority to EP08015742A priority patent/EP2050825A1/en
Priority to PCT/GB1998/001261 priority patent/WO1998049342A1/en
Priority to PT03075068T priority patent/PT1323728E/pt
Priority to PT98919350T priority patent/PT979308E/pt
Priority to AT98919350T priority patent/ATE286143T1/de
Priority to AU72226/98A priority patent/AU7222698A/en
Priority to US09/429,003 priority patent/US6720138B2/en
Priority to NO19995296A priority patent/NO317247B1/no
Priority to HK0105132A priority patent/HK1026003A1/xx
Priority to US10/727,576 priority patent/US20040121390A1/en
Priority to HK03109502.9A priority patent/HK1057217A1/xx
Priority to NO20040371A priority patent/NO327084B1/no
Priority to US11/149,370 priority patent/US20050227286A1/en
Priority to CY20091100076T priority patent/CY1108716T1/el
Priority to US13/932,615 priority patent/US20130337446A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO972006A 1997-04-30 1997-04-30 Ny metode for diagnose av sykdommer NO972006D0 (no)

Priority Applications (26)

Application Number Priority Date Filing Date Title
NO972006A NO972006D0 (no) 1997-04-30 1997-04-30 Ny metode for diagnose av sykdommer
AU72226/98A AU7222698A (en) 1997-04-30 1998-04-30 Method of preparing a standard diagnostic gene transcript pattern
PCT/GB1998/001261 WO1998049342A1 (en) 1997-04-30 1998-04-30 Method of preparing a standard diagnostic gene transcript pattern
PT98919350T PT979308E (pt) 1997-04-30 1998-04-30 Metodo de preparacao de um padrao tipo de um transcrito genetico para diagnostico
EP98919350A EP0979308B1 (en) 1997-04-30 1998-04-30 Method of preparing a standard diagnostic gene transcript pattern
DK03075068T DK1323728T3 (da) 1997-04-30 1998-04-30 Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster
JP54675698A JP4163758B2 (ja) 1997-04-30 1998-04-30 標準診断用遺伝子転写産物パターンの調製方法
DE69840154T DE69840154D1 (de) 1997-04-30 1998-04-30 Verfahren zur Diagnose der Alzheimer Erkrankung auf der Basis eines Gen Transkriptionsmusters
DK98919350T DK0979308T3 (da) 1997-04-30 1998-04-30 Fremgangsåde til fremstilling af et diagnostisk standard gen-transkriptmönster
ES03075068T ES2316693T3 (es) 1997-04-30 1998-04-30 Metodo de diagnostico de la enfermedad de alzheimer sobre la base de un patron de transcripcion genico.
ES98919350T ES2230688T3 (es) 1997-04-30 1998-04-30 Metodo para preparar un patron estandar de diagnostico de transcritos genicos.
AT03075068T ATE412003T1 (de) 1997-04-30 1998-04-30 Verfahren zur diagnose der alzheimer erkrankung auf der basis eines gen transkriptionsmusters
EP08015742A EP2050825A1 (en) 1997-04-30 1998-04-30 Method of preparing a standard diagnostic gene transcript pattern
DE69828392T DE69828392T2 (de) 1997-04-30 1998-04-30 Verfahren zur Herstellung eines diagnostischen Standard-Gentranskriptionsmusters
PT03075068T PT1323728E (pt) 1997-04-30 1998-04-30 Método de diagnóstico da doença de alzheimer com base num padrão de transcrição génica
EP03075068A EP1323728B1 (en) 1997-04-30 1998-04-30 Method of diagnosing Alzheimer' s disease on the basis of a gene transcript pattern
AT98919350T ATE286143T1 (de) 1997-04-30 1998-04-30 Verfahren zur herstellung eines diagnostischen standard-gentranskriptionsmusters
NO19995296A NO317247B1 (no) 1997-04-30 1999-10-29 Fremgangsmate for fremstilling av et standard diagnostisk gentranskripsjonsmonster
US09/429,003 US6720138B2 (en) 1997-04-30 1999-10-29 Method of preparing a standard diagnostic gene transcript pattern
HK0105132A HK1026003A1 (en) 1997-04-30 2000-08-16 Method of preparing a standard diagnostic gene transcript pattern.
US10/727,576 US20040121390A1 (en) 1997-04-30 2003-12-05 Method of preparing a standard diagnostic gene transcript pattern
HK03109502.9A HK1057217A1 (en) 1997-04-30 2003-12-31 Method of diagnosing alzheimer' s disease on the basis of a gene transcript pattern
NO20040371A NO327084B1 (no) 1997-04-30 2004-01-27 Fremgangsmate for isolering av mRNA eller cDNA-prober, samt anvendelse derav for fremstilling av et standard diagnostisk gentranskripsjonsmonster og probetestsett og anvendelse av fremgangsmaten for diagnostisering eller identifisering av en sykdom.
US11/149,370 US20050227286A1 (en) 1997-04-30 2005-06-10 Method of preparing a standard diagnostic gene transcript pattern
CY20091100076T CY1108716T1 (el) 1997-04-30 2009-01-21 Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου.
US13/932,615 US20130337446A1 (en) 1997-04-30 2013-07-01 Method of preparing a standard diagnostic gene transcript pattern

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO972006A NO972006D0 (no) 1997-04-30 1997-04-30 Ny metode for diagnose av sykdommer

Publications (1)

Publication Number Publication Date
NO972006D0 true NO972006D0 (no) 1997-04-30

Family

ID=19900683

Family Applications (2)

Application Number Title Priority Date Filing Date
NO972006A NO972006D0 (no) 1997-04-30 1997-04-30 Ny metode for diagnose av sykdommer
NO20040371A NO327084B1 (no) 1997-04-30 2004-01-27 Fremgangsmate for isolering av mRNA eller cDNA-prober, samt anvendelse derav for fremstilling av et standard diagnostisk gentranskripsjonsmonster og probetestsett og anvendelse av fremgangsmaten for diagnostisering eller identifisering av en sykdom.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20040371A NO327084B1 (no) 1997-04-30 2004-01-27 Fremgangsmate for isolering av mRNA eller cDNA-prober, samt anvendelse derav for fremstilling av et standard diagnostisk gentranskripsjonsmonster og probetestsett og anvendelse av fremgangsmaten for diagnostisering eller identifisering av en sykdom.

Country Status (13)

Country Link
US (4) US6720138B2 (no)
EP (3) EP0979308B1 (no)
JP (1) JP4163758B2 (no)
AT (2) ATE286143T1 (no)
AU (1) AU7222698A (no)
CY (1) CY1108716T1 (no)
DE (2) DE69828392T2 (no)
DK (2) DK1323728T3 (no)
ES (2) ES2316693T3 (no)
HK (2) HK1026003A1 (no)
NO (2) NO972006D0 (no)
PT (2) PT979308E (no)
WO (1) WO1998049342A1 (no)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
CA2359816C (en) * 1999-01-06 2010-08-03 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20070031841A1 (en) * 2001-02-28 2007-02-08 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20060134635A1 (en) * 2001-02-28 2006-06-22 Chondrogene Limited Method for the detection of coronary artery disease related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US6365376B1 (en) * 1999-02-19 2002-04-02 E. I. Du Pont De Nemours And Company Genes and enzymes for the production of adipic acid intermediates
CA2364877C (en) * 1999-03-10 2013-01-08 Cold Spring Harbor Laboratory Gene chip technology for determining memory genes
US7005256B1 (en) 1999-03-10 2006-02-28 Cold Spring Harbor Laboratory Gene chip technology for determining memory genes
JP2003504007A (ja) * 1999-05-19 2003-02-04 マイトコー 神経変性性疾患における脳の特異的な領域での異なる遺伝子発現
JP2005500832A (ja) 2001-06-18 2005-01-13 ロゼッタ・インファーマティクス・インコーポレーテッド 乳癌患者の診断および予後
US20050064446A1 (en) * 2001-11-01 2005-03-24 Minerva Biotechnologies Corporation Detection of binding species with colloidal and non-colloidal structures
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method
US7790867B2 (en) 2002-12-05 2010-09-07 Rosetta Genomics Inc. Vaccinia virus-related nucleic acids and microRNA
FR2853907B1 (fr) * 2003-04-18 2007-08-03 Commissariat Energie Atomique Procede de preparation de fragments d'adn par fragmentation selective d'acides nucleiques et ses applications
US7888497B2 (en) * 2003-08-13 2011-02-15 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof
WO2005076939A2 (en) * 2004-02-09 2005-08-25 University Of Kentucky Research Foundation Assay and method for diagnosing and treating alzheimer’s disease
US7593483B2 (en) * 2004-05-07 2009-09-22 Broadcom Corporation Nonlinear mapping in digital-to-analog and analog-to-digital converters
US7687616B1 (en) 2004-05-14 2010-03-30 Rosetta Genomics Ltd Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof
EP2322650A1 (en) 2004-05-14 2011-05-18 Rosetta Genomics Ltd MicroRNAs and uses thereof
US7795419B2 (en) 2004-05-26 2010-09-14 Rosetta Genomics Ltd. Viral and viral associated miRNAs and uses thereof
EP2290069A3 (en) 2004-05-28 2011-08-10 Asuragen, Inc. Methods and compositions involving microRNA
GB0412301D0 (en) * 2004-06-02 2004-07-07 Diagenic As Product and method
US7867703B2 (en) * 2004-08-26 2011-01-11 Agilent Technologies, Inc. Element defined sequence complexity reduction
US7713693B1 (en) 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
CA2857880A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
CA2599589A1 (en) * 2005-02-07 2006-08-17 Genenews,Inc. Mild osteoarthritis biomarkers and uses thereof
US20070082350A1 (en) * 2005-02-09 2007-04-12 Philip Landfield Assay and method for diagnosing and treating alzheimer's disease
WO2007100913A2 (en) * 2006-02-28 2007-09-07 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
AU2007299748A1 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. miR-15, miR-26, miR -31,miR -145, miR-147, miR-188, miR-215, miR-216 miR-331, mmu-miR-292-3p regulated genes and pathways as targets for therapeutic intervention
EP2487240B1 (en) 2006-09-19 2016-11-16 Interpace Diagnostics, LLC Micrornas differentially expressed in pancreatic diseases and uses thereof
US20090029868A1 (en) * 2006-10-31 2009-01-29 Applera Corporation Expression signature in peripheral blood for detection of aortic aneurysm
EP2104734A2 (en) * 2006-12-08 2009-09-30 Asuragen, INC. Mir-20 regulated genes and pathways as targets for therapeutic intervention
CN101675165A (zh) * 2006-12-08 2010-03-17 奥斯瑞根公司 Let-7微小rna的功能和靶标
US20090092974A1 (en) * 2006-12-08 2009-04-09 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
WO2008073920A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Mir-21 regulated genes and pathways as targets for therapeutic intervention
CA2671270A1 (en) * 2006-12-29 2008-07-17 Asuragen, Inc. Mir-16 regulated genes and pathways as targets for therapeutic intervention
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
EP2167138A2 (en) * 2007-06-08 2010-03-31 Asuragen, INC. Mir-34 regulated genes and pathways as targets for therapeutic intervention
WO2009036332A1 (en) * 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009052386A1 (en) * 2007-10-18 2009-04-23 Asuragen, Inc. Micrornas differentially expressed in lung diseases and uses thereof
WO2009070805A2 (en) * 2007-12-01 2009-06-04 Asuragen, Inc. Mir-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (en) * 2007-12-21 2009-07-09 Asuragen, Inc. Mir-10 regulated genes and pathways as targets for therapeutic intervention
EP2260110B1 (en) * 2008-02-08 2014-11-12 Asuragen, INC. miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
EP2271757A2 (en) * 2008-03-26 2011-01-12 Asuragen, INC. Compositions and methods related to mir-16 and therapy of prostate cancer
US20090258928A1 (en) * 2008-04-08 2009-10-15 Asuragen, Inc. Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
WO2009137807A2 (en) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
EP2318551A4 (en) * 2008-08-27 2012-10-24 Lundbeck & Co As H SYSTEM AND METHOD FOR MEASURING BIOMARKER PROFILES
WO2010056737A2 (en) * 2008-11-11 2010-05-20 Mirna Therapeutics, Inc. Methods and compositions involving mirnas in cancer stem cells
GB201000688D0 (en) 2010-01-15 2010-03-03 Diagenic Asa Product and method
ES2631458T3 (es) 2010-03-04 2017-08-31 Interna Technologies B.V. Molécula de ARNmi definida por su fuente y sus usos terapéuticos en el cáncer asociado a la EMT
EP3369817A1 (en) 2010-07-06 2018-09-05 InteRNA Technologies B.V. Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma , or in diseases or conditions with activated braf pathway
JP6155194B2 (ja) 2010-11-17 2017-06-28 インターペース ダイアグノスティックス リミテッド ライアビリティ カンパニー 良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのｍｉＲＮＡ
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
CA2826043A1 (en) 2011-02-03 2012-08-09 Mirna Therapeutics, Inc. Synthetic mimics of mir-124
EP2681566A2 (en) 2011-02-28 2014-01-08 University of Iowa Research Foundation Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
US9746458B2 (en) * 2011-04-27 2017-08-29 Loma Linda University Medical Center Dynactin subunit p62 biomarker for neurological conditions
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
US20130157884A1 (en) 2011-10-26 2013-06-20 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (en) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
WO2013064702A2 (en) 2011-11-03 2013-05-10 Diagenic Asa Probes for diagnosis and monitoring of neurodegenerative disease
EP2870263A1 (en) 2012-07-03 2015-05-13 InteRNA Technologies B.V. Diagnostic portfolio and its uses
WO2014055117A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
EP2971149B1 (en) 2013-03-15 2018-05-09 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
WO2014145612A1 (en) 2013-03-15 2014-09-18 Ajay Goel Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
EP4163387A1 (en) 2013-03-15 2023-04-12 The University of Chicago Methods and compositions related to t-cell activity
WO2019086603A1 (en) 2017-11-03 2019-05-09 Interna Technologies B.V. Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
CN113924085A (zh) 2019-04-12 2022-01-11 加利福尼亚大学董事会 用于增加肌肉量和氧化代谢的组合物和方法
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
JP2802125B2 (ja) 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
DE69214243T2 (de) * 1991-09-23 1997-02-06 Pfizer Verfahren für die Detektion von spezifische mRNS und DNS in Zellen
GB2260811B (en) 1991-10-23 1995-07-05 Yorkshire Cancer Research Camp Detection of malignant tumours
US5658786A (en) 1992-03-04 1997-08-19 Synaptic Pharmaceutical Corporation DNA encoding rat taurine transporter and uses thereof
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
EP0667920B1 (en) * 1992-10-29 2003-01-15 Thomas Jefferson University Methods of detecting micrometastasis of prostate cancer
US5633137A (en) 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
JP2000504575A (ja) 1996-02-08 2000-04-18 アフィメトリックス，インコーポレイテッド 微生物のチップベースの種分化および表現型特徴付け
AU4327697A (en) 1996-08-20 1998-03-06 Motorola, Inc. Method and apparatus for detecting predetermined molecular structures in a sample
AU722819B2 (en) * 1996-12-06 2000-08-10 Urocor, Inc. Diagnosis of disease state using mRNA profiles
US6235474B1 (en) 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
WO1999006831A2 (en) 1997-07-29 1999-02-11 Dorssers Lambert C J Breast cancer resistance genes, methods for their detection and uses thereof
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
EP1066517B1 (en) 1998-02-25 2006-11-29 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Cellular arrays for rapid molecular profiling
US6004755A (en) 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
KR20010072846A (ko) 1998-08-21 2001-07-31 추후제출 가교결합성 고정 핵산을 사용하는 분석법
EP1121471A1 (en) 1998-10-13 2001-08-08 Clontech Laboratories, Inc. Nucleic acid arrays
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000024940A1 (en) 1998-10-28 2000-05-04 Vysis, Inc. Cellular arrays and methods of detecting and using genetic disorder markers
WO2000026412A1 (en) 1998-11-02 2000-05-11 Kenneth Loren Beattie Nucleic acid analysis using sequence-targeted tandem hybridization
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040265869A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
CA2359816C (en) * 1999-01-06 2010-08-03 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20040241727A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20020169560A1 (en) * 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data

Also Published As

Publication number Publication date
US20130337446A1 (en) 2013-12-19
PT979308E (pt) 2005-03-31
ES2316693T3 (es) 2009-04-16
DK1323728T3 (da) 2009-03-02
WO1998049342A1 (en) 1998-11-05
DE69828392T2 (de) 2005-12-01
DK0979308T3 (da) 2005-04-18
DE69828392D1 (de) 2005-02-03
EP1323728A3 (en) 2004-02-04
EP1323728A2 (en) 2003-07-02
NO20040371L (no) 1999-12-14
HK1026003A1 (en) 2000-12-01
EP0979308B1 (en) 2004-12-29
US6720138B2 (en) 2004-04-13
NO327084B1 (no) 2009-04-20
HK1057217A1 (en) 2004-03-19
PT1323728E (pt) 2009-01-23
US20040121390A1 (en) 2004-06-24
ATE286143T1 (de) 2005-01-15
EP0979308A1 (en) 2000-02-16
JP2001526534A (ja) 2001-12-18
DE69840154D1 (de) 2008-12-04
EP1323728B1 (en) 2008-10-22
CY1108716T1 (el) 2014-04-09
ES2230688T3 (es) 2005-05-01
AU7222698A (en) 1998-11-24
US20020022222A1 (en) 2002-02-21
US20050227286A1 (en) 2005-10-13
ATE412003T1 (de) 2008-11-15
JP4163758B2 (ja) 2008-10-08
EP2050825A1 (en) 2009-04-22

Similar Documents

Publication Publication Date Title
NO972006D0 (no) Ny metode for diagnose av sykdommer
GB2383043A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
EP1813684A3 (en) Differently expressed genes in healthy and diseased subjects
WO2000077260A8 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
EP1215495A3 (de) Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
WO2004075733A3 (en) Construction of a deafness gene chip
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2002022879A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2002074911A3 (en) Identification of gene expression alterations underlying the aging process in mammals
WO2000070340A3 (en) Materials and methods relating to disease diagnosis
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
DE60121547T2 (de) Elektrochemisches Verfahren zum Nachweis von Nukleinsäuren
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs
WO2003091410A3 (en) Method of fingerprinting tissue samples
DE69535023D1 (de) Ein diagnose-verfahren und ein testsatz für die bestimmung des kell blutgruppln-nenotyps
ATE478147T1 (de) Aus einem neuroblastom isolierte nukleinsäuren
DE60035857D1 (de) Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen
JPH04135498A (ja) 遺伝子検出方法
FR2786787B1 (fr) Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
EP0991780A2 (de) Verfahren und testkit zum nachweis bösartiger tumore
CN112135913A (zh) 使用等温核酸扩增对生物组织三维核酸成像诊断的方法
KR20000072201A (ko) 여러 종류의 디엔에이 프로브들을 사용한 취약-엑스증후군의 진단 방법
WO2007041359B1 (en) Compositions and methods relating to cornelia de lange syndrome